Narrow search
Showing 1 - 10 of 12,477
Cover Image
Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico
Santiago-Rodriguez, Fernando; Dutrenit, Gabriela - United Nations University, Maastricht Economic and … - 2010
systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by …
Persistent link: https://www.econbiz.de/10008693155
Cover Image
Global Framework for Differential Pricing of Pharmaceuticals
Daems, Rutger; Maes, Edith; Ramani, Shyama V. - United Nations University-Maastricht Economic Research … - 2011
This paper examines how equitable, differentiated pricing can improve access to and affordability of medicines, particularly in low- and middle-income countries, and how governments and supranational agencies can create an environment that enables pharmaceutical companies to operate a...
Persistent link: https://www.econbiz.de/10010856414
Cover Image
Study of logistics issues in the Indian pharmaceutical industry
Puri, Sandeep; Ranjan, Jayanthi - In: International Journal of Logistics Economics and … 4 (2012) 3, pp. 150-161
Indian pharmaceutical industry is one of the fastest growing sectors of Indian economy but the medicines we take suffer from serious ills: they are not stored and transported the way they ought to be. Pharmaceutical companies face issues related to choosing and working with the right logistics...
Persistent link: https://www.econbiz.de/10010668805
Cover Image
Determinants of PRO-industry interactions in pharmaceutical R&D: the case of Mexico
Santiago-Rodriguez, Fernando; Dutrenit, Gabriela - United Nations University-Maastricht Economic Research … - 2010
systems of innovation. Limited interaction contributes to explain poor performance in R&D and ultimately, in innovation by …
Persistent link: https://www.econbiz.de/10010712332
Cover Image
Tendering and decision-making: a case on pharmaceutical products
Dankers, Sven; Vieira, Rui - In: World Review of Entrepreneurship, Management and … 8 (2012) 2, pp. 236-263
In order to contain expenditures for pharmaceuticals, the latest healthcare reforms have focused on decentralising …
Persistent link: https://www.econbiz.de/10010670125
Cover Image
Discussion Note: Draft National Pharmaceutical Policy 2006
Network, All-India Drug Action - eSocialSciences - 2006
A note on the long-awaited Draft National Pharmaceutical Policy 2006. The Policy appears to have taken into consideration consumer needs, paying respect to rational therapeutics. A closer examination of the details---which is what policy critique should do—shows a patchy effort that may...
Persistent link: https://www.econbiz.de/10005696014
Cover Image
The Sectoral System of Innovation of Indian Pharmaceutical Industry
Mani, Sunil - eSocialSciences - 2008
The paper undertakes a detailed mapping out of the sectoral system of innovation of India's pharmaceutical industry …. The industry is one of the most innovative industries in the Indian manufacturing sector. The innovation system of the … right, strong government research institutes and private sector enterprises which have invested in innovation. The TRIPS …
Persistent link: https://www.econbiz.de/10005699264
Cover Image
Pharmaceuticals, WTO/TRIPs and Women
Srinivasan, S - eSocialSciences - 2005
This paper looks at the effects of WTO/TRIPS and pharmaceuticals on women. The focus is on the poor and women. The … benefits of health and modern pharmaceuticals. Access to generic low-priced medicines – including medicines for HIV AIDS …
Persistent link: https://www.econbiz.de/10005699276
Cover Image
Long-term value creation in the pharmaceutical sector: an event study analysis of big pharma stocks
Tomovic, Andrija; Atukeren, Erdal - In: International Journal of Sustainable Economy 4 (2012) 4, pp. 370-389
We investigate the drivers of value creation in big pharmaceutical firms. We use a unique dataset of a total of 2,200 news items on research and development (R%D) progress announcements and dividend news of 25 largest pharmaceutical companies for the period 1998-2010. Our findings affirm the...
Persistent link: https://www.econbiz.de/10010668634
Cover Image
Sustainable use of biodiversity by the pharmaceutical industry?
Gebhardt, Martina - In: International Journal of Sustainable Development 1 (1998) 1, pp. 63-72
biodiversity through the creation of pharmaceuticals. …
Persistent link: https://www.econbiz.de/10008563737